LOC646862 Activators
LOC646862 can initiate various signaling cascades resulting in the protein's activation. Forskolin, by elevating intracellular cAMP levels, sets off a chain reaction where protein kinase A (PKA) is activated. PKA, in turn, can phosphorylate LOC646862, leading to its activation if LOC646862 is a PKA substrate. Similarly, IBMX increases cAMP levels by inhibiting phosphodiesterases, hence preventing cAMP breakdown and potentially enhancing PKA activity. An increase in PKA activity can facilitate the phosphorylation and subsequent activation of LOC646862. Dibutyryl-cAMP, which is a cell-permeable analog of cAMP, directly activates PKA and subsequently could also activate LOC646862 through phosphorylation.
Ionomycin, by increasing intracellular calcium levels, may activate calmodulin-dependent kinase (CaMK), which then can phosphorylate LOC646862, provided that LOC646862 is regulated by CaMK-dependent pathways. PMA and TPA, as activators of protein kinase C (PKC), can initiate LOC646862 phosphorylation if LOC646862 is a PKC substrate. Epinephrine, by binding to adrenergic receptors, can trigger cAMP-dependent pathways, leading to PKA activation which then can phosphorylate LOC646862. Glutamate, through its action on metabotropic receptors, can activate phospholipase C, increasing the production of diacylglycerol and inositol trisphosphate, which can stimulate PKC and potentially lead to the activation of LOC646862. Bradykinin, upon engaging its receptor, also activates PKC through the phospholipase C pathway and could have a similar effect on LOC646862. Insulin, through the PI3K/Akt pathway, can lead to the phosphorylation of downstream proteins, potentially including LOC646862 if it lies within this pathway. Anisomycin stimulates the MAPK pathway, including activation of JNK and p38 kinases, which can lead to the activation of LOC646862 through phosphorylation. Lastly, H-89, which normally inhibits PKA, can paradoxically increase PKA activity at higher concentrations, potentially resulting in the phosphorylation and activation of LOC646862.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, preventing the breakdown of cAMP. The resulting increase in cAMP levels could enhance PKA activity, which may phosphorylate and activate LOC646862 if the protein's activity is regulated by cAMP/PKA signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate and activate LOC646862 if it is a substrate of PKC or is in a pathway regulated by PKC. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. This rise in calcium can activate calmodulin-dependent kinase (CaMK), which may lead to the phosphorylation and activation of LOC646862 if it is regulated by CaMK-dependent signaling pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, leading to activation of cAMP-dependent pathways. This can activate PKA, which may phosphorylate and activate LOC646862 if the protein is regulated by adrenergic signaling through cAMP and PKA. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate acts on metabotropic glutamate receptors to activate phospholipase C, which increases inositol trisphosphate and diacylglycerol, leading to the activation of PKC. PKC may then activate LOC646862 if it is regulated by calcium/PKC signaling pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which can lead to the phosphorylation and activation of downstream proteins. LOC646862 may be activated by Akt if it is a downstream target in the insulin signaling pathway. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that can activate PKA. Activated PKA may phosphorylate and activate LOC646862 if the protein is within the PKA signaling pathway. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin stimulates the MAPK pathway, which includes the activation of JNK and p38 kinases. These kinases can phosphorylate and activate downstream proteins, potentially including LOC646862 if it is part of the MAPK pathway. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Despite being a peptide, bradykinin's action on its receptor leads to the activation of PLC, producing IP3 and DAG and subsequently activating PKC. PKC may then activate LOC646862 if it is a part of or regulated by pathways involving PKC. | ||||||